Register
Login:
Share:
Email Facebook Twitter

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018 Watch here

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money'


N4 Pharma Plc Share Price (N4P)



Share Price Information for N4 Pharma Plc (N4P)


Share Price: 7.875Bid: 7.75Ask: 8.00Change: -0.25 (-3.08%)Faller - N4 Pharma Plc
Spread: 0.25Spread as %: 3.23%Open: 8.125High: 8.125Low: 7.75Yesterday’s Close: 8.125

N4 Pharma Plc Ord 0.4P

N4 Pharma Plc is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
7.875

Share Price SpacerBid
7.75

Share Price SpacerAsk
8.00

Share Price SpacerChange
-3.08%-0.25

Share Price SpacerVolume
168,080

Share Price SpacerOpen
8.125

Share Price SpacerHigh
8.125

Share Price SpacerLow
7.75

Share Price SpacerClose
8.125

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 74.71m £5.88m 15,000

52 Week High 12.38 52 Week High Date 1-JUN-2017
52 Week Low 4.88 52 Week Low Date 1-AUG-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
7 162,720 5,360 -98.438 -0.08 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

22-Nov-17
16:22:18
7.7751
17,486
Sell* 
7.75
8.00
1,360
Trade Type:
Ordinary

22-Nov-17
13:47:47
7.7751
2,000
Sell* 
7.75
8.00
155.50
Trade Type:
Ordinary

22-Nov-17
12:25:22
7.75
77,420
Sell* 
7.75
8.25
6,000
Trade Type:
Ordinary




View more N4 Pharma Plc trades >>

Directors Deals for N4 Pharma Plc (N4P)
Trade DateActionNotifierPriceCurrencyAmountHolding
10-Nov-17Buy
Trade Notifier Information for N4 Pharma
Nigel Theobald held the position of CEO at N4 Pharma at the time of this trade.
 Nigel Theobald
7.92GBX56,65612255233
View more N4 Pharma Plc directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Tue 15:49beggermazik8.125No Opinion
Im thinking multiples of that really. It will curtainly do for now :) no rush ill try and get a few more till then
Tue 15:23AnthonyJamesStrong bid8.125No Opinion
Yet again guys. Will take 500k off me in one hit... Any sustained buying, even small amounts, and we're ticking up again. Just like last week and the week before...
Tue 09:32mazikTree shake8.00No Opinion
As per normal I suspect mm need shares, buyers are mopping on any weakness
Mon 18:52mazikRE: Nigel buying8.125No Opinion
The value of the global nanotechnology drug delivery market is forecast to grow from $4.1 billion in 2014 to $11.9 billion in 2023*.
As nuvec£ continues to meet its technical targets, it becomes very clear that we have the potential to become a significant player in this growing market. We will continue its development to determine how best to compete and to take the technology forward." A lot of mileage in N4p sp
Mon 18:33mazikRE: mm games8.125No Opinion
Weird for sure a sell of 10k shares at 4:15 takes of 3% increase and takes off 1.52%. of the sp..hmm, well i will keep my 400k until infinity when the sp is 80p in 2018....i will think :-)
Mon 17:10beggermm games8.125No Opinion
That was a wiered one wasnt it !

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for N4 Pharma Plc (N4P) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.